Biotech IPO window is opening but big pharma M&A still sets the pace, top bankers tell CNBC
Biopharma dealmaking is driven by pressure to top up drug pipelines ahead of major patent expirations later this decade.
The Source
CNBC
US
Qualcomm CEO says AI agents will replace apps — as chip giant works on 40 new AI-powered devices
CNBC·4h ago·3 min read
Business
Centene to offer buyouts to some employees as health insurer cuts costs
CNBC·12h ago·3 min read
US
Gavin Newsom says Trump ordered DOJ to investigate him and his wife
CNBC·13h ago·3 min read
US
Nvidia plans to raise about $20 billion in first debt sale since start of AI boom
CNBC·13h ago·3 min read
Related
On this beat
Health
Kennedy Orders Woman to Stay in Hantavirus Quarantine, Despite C.D.C. Recommendation
TNYT·11h ago·3 min read
Health
Level 3 – Ebola Bundibugyo Virus Disease in Parts of the Democratic Republic of the Congo
CDC·1d ago·3 min read
Health
Kennedy Seeks to Expedite Appeal of Ruling That Blocked His Vaccine Policies
TNYT·16h ago·3 min read
Health
How Does One Brain Speak Two Languages?
TNYT·15h ago·3 min read